Speed Has a Price: A Small Shareholder’s Audit of UK Placings

UK equity fundraising has become a test of patience for small shareholders. A company can announce a placing after the close, complete a bookbuild overnight and publish the result before most private investors have read the announcement. The appeal for the board is obvious: capital is secured while the market is still open to it. The cost is less obvious, because it is spread across existing holders in the form of dilution, lost entitlement and, sometimes, a weaker voice in future decisions.

None of this makes placings illegitimate. A well-timed, well-priced placing can strengthen a balance sheet and fund growth that benefits all holders. But the growing use of placings, and of cashbox structures that achieve similar ends, means small shareholders need a framework for separating a necessary fundraiser from a convenient one.

Why speed has become the default

A rights issue is the traditional UK route. It offers existing shareholders the chance to subscribe in proportion to their holding, usually at a discount, and it preserves pre-emption rights. It is also slow. A rights issue can take weeks to document, timetable and complete, and it exposes the company to market risk during that period. An open offer can widen participation, but it still takes time and involves costs.

A placing is faster. The company, or its brokers, canvass institutional investors and price the shares in a bookbuild. The discount compensates buyers for taking size quickly and for the risk that the shares may fall before settlement. For a company facing a time-sensitive acquisition or refinancing, that speed can be worth paying for.

The question for small shareholders is who pays. In a placing, the buyer receives shares at a discount to the market price. Existing holders are diluted. If the company could have raised the same money through a fairly priced rights issue, the placing discount is not a free lunch; it is a transfer to the new buyers. The transfer may be justified, but it should be visible and measured.

What the discount actually measures

The headline placing discount is usually quoted against the last closing price or an undisturbed price before announcement. That number matters, but it is incomplete. A placing at 8 per cent below the last close is not simply an 8 per cent cost to existing holders. The economic cost is the discount multiplied by the new money raised, plus the dilution of each holder’s proportional claim on the company’s future cash flows.

Suppose a company raises £100m at a 10 per cent discount. The immediate value transfer to the new subscribers is roughly £10m, before costs. If the money is invested in a project that earns a return above the company’s cost of capital, existing holders can still be better off over time. If it is used to repay expensive debt, the arithmetic may also work. If it plugs a working-capital shortfall with no clear path to returns, the discount is a symptom of a weaker hand.

The relevant comparison is not only the last close. It is the discount relative to the volume-weighted average price over a sensible period, the volatility of the stock and the size of the raise relative to the company’s market value. A large placing in a thinly traded small cap almost always needs a wider discount; that does not make it value-destructive, but it does raise the bar for the use of proceeds.

Waivers, windows and cashboxes

Pre-emption rights are a statutory protection for UK shareholders, but they can be disapplied by shareholder authority. Listed companies routinely seek authority to allot shares and to disapply pre-emption rights up to certain limits. The Pre-Emption Group’s Statement of Principles, updated in 2022, sets out expectations around the use of those authorities, including the customary 10 per cent general authority and additional flexibility for acquisitions and follow-on retail offers. The detail matters: authority used for a placing is authority that cannot be used again without fresh approval.

Cashbox structures are more complex. In simplified terms, shares are issued to a vehicle and exchanged for cash, allowing a company to raise money without a conventional pre-emptive offer. These structures have attracted scrutiny because they can achieve the economic result of a placing while relying on technical features of company law. For a small shareholder, the practical test is whether the company explains clearly why a cashbox was used, how it treats pre-emption and whether retail holders are offered a meaningful route to participate.

Retail offer windows are often the most overlooked part of the announcement. Some placings include a retail offer through a platform or broker, usually at the same price as the institutional placing. The size can be small relative to the total raise, and the window can be short. A retail offer is better than none, but it is not a substitute for pre-emption. Shareholders should check the size, the timetable, the minimum subscription and whether their broker can actually access it.

When a fundraising is genuinely accretive

Accretion is not the same as an increase in earnings per share. A placing can be EPS-accretive simply because the company buys a business with a lower earnings multiple, even if the acquired business is poor quality or the balance sheet becomes stretched. The better test is whether the money raised earns a return above the company’s cost of capital, after integration costs and risks.

For a growth company, that may mean a clear path to higher returns on new capital. For a mature company, it may mean reducing leverage or funding maintenance capital expenditure that protects cash flow. For a rescue fundraising, the test is different again: survival may be the priority, but shareholders should still ask whether the terms disproportionately favour new money and whether existing holders have a fair chance to follow.

Insider participation is another signal. Directors and major shareholders may subscribe in a placing, which can align interests. But their participation should be read alongside the discount and the size of their existing stakes. If insiders are buying at a discount while small holders are excluded, the governance question is legitimate even if the fundraising is commercially sound.

A practical checklist for small shareholders

1. Why now? Is the money needed for a specific, time-sensitive opportunity, a refinancing or a shortfall? A vague answer is a warning.
2. What was the alternative? Did the company consider a rights issue, open offer or smaller raise? The circular should explain the choice, not merely assert that a placing was faster.
3. How large is the discount? Compare it with the last close, the recent VWAP and the stock’s volatility. A wide discount in a volatile small cap is not automatically bad, but it needs justification.
4. How much authority is being used? Check the disapplication limits and whether the company is using acquisition or retail follow-on allowances. Repeated use of authority without refresh is a governance flag.
5. Can I participate? Look for a retail offer, its size, price and timetable. If there is none, ask why.
6. What will the money do? Require a return on capital test, not just an EPS accretion claim. Check leverage, integration risk and the track record of management.
7. Who is buying? Insider and major holder participation can be reassuring, but it does not neutralise the dilution of those excluded.
8. What happens next? A placing often precedes further capital needs. Read the statement for follow-on plans, covenants and acquisition earn-outs.

The price of dispatch

UK markets need companies to be able to raise capital quickly. A rigid attachment to rights issues in every circumstance would leave some companies unable to act when opportunities or threats arrive. But speed has a price, and that price is paid by the holders who are not in the bookbuild.

The sensible response for small shareholders is not to oppose every placing. It is to demand that the discount, the waiver and the retail window are explained in plain terms, and that the use of proceeds is judged against a credible return on capital. A fundraising that passes those tests can be value-accretive. One that fails them is merely convenient for the people in the room.